Because adrenal cancer is so rare, very few cancer hospitals have specialists equipped to treat patients and perform research and offer clinical trials for this type of cancer. “Very few physicians ever see a case in their lifetime and so there are a lot of physicians out there who don’t really understand the disease process,” said Barbra Miller, MD, the co-director of the James Multidisciplinary Adrenal Clinic. “I want to make sure patients get good, consistent and comprehensive and safe care and as a surgeon I want to make sure every patient gets the best surgery.” In this episode, Miller and Priya Dedhia, MD, PhD, a James expert in adrenal surgery and research, discussed this rare form of cancer and the wide range of screening and treatment options at the James, and their cutting-edge research. There are currently no screening procedures, such as mammograms for breast cancer or colonoscopies for colon cancer. This means adrenal cancer is often first diagnosed in the later stages when it has metastasized and spread. “We don’t know there’s a tumor until it’s quite large or has gone somewhere else, and another way we know is if [the cancerous adrenal gland] overproduces hormones,” Miller said. Some of the research at the James is focused on understanding how benign tumors in the adrenals can become cancerous. “We know colon cancer starts as a benign polyp,” Miller said. “We never thought this was true with adrenal cancer but now we’re at the stage where we think we can prove this is true.” Surgery is the primary modality for treating adrenal cancer, often followed by chemotherapy or, in recent years, immunotherapy. “We’re working to create new models for adrenal cancer treatment,” Dedhia said, adding that in her lab she has created “organoids” that “are like patient avatars and help us better understand and treat the cancer.” Organoids are masses of cells grown in the lab and can be used to test the effectiveness of new drug treatments, such as immunotherapy, prior to clinical trials in patients. “We’ve found two new pathways that kill these organoid cells and the next step we’re hoping for is a clinical trial,” Dedhia said. “We believe we’ve found a way to improve the immune response [of new immunotherapy drugs] and we’re very excited.”

Episode 162: New Research & Treatment for Adrenal Cancers, Drs. Dedhia and Miller

Event Coordinator for Jackson County Relay for Life joined WXAN to talk about numerous events they have upcoming in the month of May and June.

Paula Maloney Interview 5 - 2 - 24

Dr Raj Jena talks about his research on analysis of the images used for radiotherapy planning and for modelling the effects and outcomes of radiotherapy treatment. As a clinician, he uses radiotherapy and drug treatments on patients with tumours in the brain or spine. He also talks about the InnerEye Project, a collaboration with Microsoft Cambridge, which uses algorithms to map and segment tumours from CT/MRI scans.

Raj is a Clinical Consultant and Radiation Oncologist at Cambridge University Hospitals NHS Foundation Trust, UK, and is a member of the CRUK Cambridge Centre at the University of Cambridge, UK.

Integrated Cancer Medicine: Research in Focus

Using AI to map tumours: The InnerEye Project

A conversation with Dr. Diljeet Singh about health insurance, cancer and exercise research, navigating integrative cancer care, tips for finding moments of mindfulness. 

Dr. Singh's bio: Diljeet K. Singh is a women’s health advocate and an integrative gynecologic oncologist currently based in Washington DC. Dr. Singh received her medical degree from Northwestern University and master’s degree from the Harvard School of Public Health. She completed an obstetrics and gynecology residency at the Johns Hopkins Hospital and a gynecologic oncology fellowship at the MD Anderson Cancer Center. She completed her doctoral degree in public health on cost analysis at the University of Texas School of Public Health and an associate fellowship in integrative medicine at the University of Arizona. She is a long time member of the advisory board for FORCE Facing Hereditary Cancer EMPOWERED and the President-Elect of Physicians for a National Health Program.

Resources mentioned in the podcast:
Andy Weil 4-7-8 breath: https://www.youtube.com/watch?v=p8fjYPC-k2k
ACS Commission on Cancer, site directory: https://www.facs.org/quality-programs/cancer-programs/commission-on-cancer/
Maple Tree Alliance, fitness resources: https://www.mapletreecanceralliance.org/
CancerChoices: Moving More: https://cancerchoices.org/healing-practice/moving-more/exercising-wisely/
Guided Imagery: https://www.youtube.com/watch?v=iyyd4MOI_R8
Research on physical activity and cancer mortality: https://academic.oup.com/jncics/article/4/1/pkz080/5582677
Research on lifestyle and breast cancer survival: https://pubmed.ncbi.nlm.nih.gov/30299404/

Meet the Practitioner: Dr. Diljeet Singh, Integrative gynecologic oncologist

In today's episode, Ellie Wolmark is joined by Professor George Vassiliou to talk about his research on clonal haematopoiesis and a new clinic that he has recently set up. We'll uncover what clonal haematopoiesis is and how it can sometimes lead to the development of blood cancer.

George is a CRUK Senior Clinical Fellow and Professor of Haematological Medicine at the University of Cambridge, UK. He is also a member of Faculty at the Wellcome-MRC Cambridge Stem Cell Institute and a Consultant Haematologist at Cambridge University Hospitals NHS Foundation Trust.

Clonal haematopoiesis and using it to try to predict whether cancer will develop

Often, the “Paul’s Page Turners” segment of the show can offer up some wild and unfathomable books to investigate, but this week’s choice is a truly mad experience. Paul and Eli may be skeptics when it comes to all things supernatural, but they’re willing to hear a story out if it shows promise. The book in question was sold in Cancer Research Charity Shops across the UK and is entitled, “The Show Must Go On: Book Two”. Written by a possibly naïve believer, Malcom Thorogood’s proof of life after death comes in the form of visitations from one of the UK’s most notorious 1980s light entertainers… Freddie Starr! The man who allegedly ate a hamster (!!) and dealt in high energy, near crazed comedy is now back from the dead to offer some mindboggling experiences from beyond the grave. Paul is gobsmacked and Eli doesn’t believe one bit of it! But hey, if you don’t like ghosts there’s an “Off Brand Brand Off” segment to enjoy. Eli must rank FIVE orange soda brands to see if the Fanta or Tango brands are up to scratch compared to some considerably cheaper alternatives! See? There’s something for everyone!

See pics/videos for this episode on our website:
https://www.thecheapshow.co.uk/ep-396-freddie-starr-swallowed-my-soul

Thanks to Alan Muggridge/@kungfoolmuggers for letting me steal this episode title from him!

And if you like us, why not support us:
www.patreon.com/cheapshow

If you want to get involved, email us at thecheapshow@gmail.com
And if you want to, follow us on Twitter/X @thecheapshowpod or @paulgannonshow & @elisnoid

www.thecheapshow.co.uk
Now on Threads: @cheapshowpod
Like, Review, Share, Comment... LOVE US!

MERCH

Official CheapShow Merch Shop:
www.redbubble.com/people/cheapshow/shop
www.cheapmag.shop

Thanks also to @vorratony for the wonderful, exclusive art:
www.tinyurl.com/rbcheapshow

Send Us Stuff:
CheapShow
PO BOX 1309
Harrow
HA1 9QJ

CheapShow

Ep 396: Freddie Starr Swallowed My Soul

This week, Ellie Wolmark is joined by Dr Claire King, Cherry May Sanchez and Dr Rhys Grant to discuss some of the amazing engagement, involvement and inclusion initiatives that we run here at the CRUK Cambridge Centre at the University of Cambridge, UK. They share how and why we engage and involve patients and the public in our research, and focus on the importance of championing equality, diversity and inclusion (EDI) in all aspects of our work. You will also hear about some of our projects for working with hard-to-reach communities, including how our Nursing and Allied Health Professionals Programme are helping to tackle health inequalities for people experiencing homelessness.

Claire is a Programme Manager for the Advanced Cancer Imaging and Cancer Immunology Programmes and an EDI Champion at the CRUK Cambridge Centre.

Cherry May is the CRUK Senior Research Nurse and co-Lead for the Nursing and Allied Health Professionals Programme at the CRUK Cambridge Centre.

Rhys is the Engagement Lead and an EDI Champion at the CRUK Cambridge Centre.

Engagement, involvement and inclusion in research

Dr Ines Machado, Dr Gabriel Funingana, Thomas Buddenkotte and Amied Shadmaan talk about the research they are undertaking within the collaborative project between GE Healthcare, the University of Cambridge and Cambridge University Hospitals NHS Foundation Trust. They also provide an update on the development of the Oncocare platform.

Ines is a Research Associate in the Crispin Lab at the CRUK Cambridge Institute, University of Cambridge, UK.

Gabriel is a Clinical Fellow and PhD student in the Department of Oncology, University of Cambridge, UK.

Thomas is a consultant to the Crispin Lab. He obtained his PhD at the University of Cambridge, UK, working at the Department of Applied Mathematics and Theoretical Physics and the Department of Radiology. He is now affiliated with the Department of Diagnostic and Interventional Radiology and Nuclear Medicine at the University Medical Center Hamburg-Eppendorf, Germany, and the Hamburg-based company Jung Diagnostics.

Amied is Director of AI & Clinical Collaborations at GE Healthcare.

AI in cancer research and an update on the GE Healthcare collaboration

A research team led by Harvard Medical School researchers have designed a new Artificial Intelligence model that may be able to diagnose and evaluate multiple different cancers. The new model, CHIEF, is up to 36% more effective at detecting cancer, determining a tumour's origin, and predicting patient outcomes than other deep learning models.

Radio ARA Programme du 2024-09-06

What's right: new AI model identifies multiple cancer types

Professor Kevin Brindle joins Ellie Wolmark to discuss his life's work in imaging research as he reaches retirement. Kevin is particularly interested in metabolic imaging. His research group has developed novel magnetic resonance-based molecular imaging techniques to detect the early responses of tumours to therapy, with a view to translating these into clinical application. He talks about how he got into this topic in the first place, his amazing contributions to the field over the past four decades, and about how his techniques can be translated into the clinic to impact patient treatment.

Kevin is Emeritus Professor of Biomedical Magnetic Resonance in the Department of Biochemistry and a Senior Group Leader in the CRUK Cambridge Institute at the University of Cambridge, UK. He is also a Fellow of the Academy of Medical Sciences and of the Royal Society.

Kevin Brindle – Reflections on a lifetime in imaging research

SAHMRI-based supportive oncology researcher, Dr Hannah Wardill has been nominated for the 2025 Australian of the Year off the back of her prolific body of work, which includes 85 peer-reviewed articles, numerous awards and more than $15 million in funding.

Dr Hannah Wardill - 2025 SA Australian of the Year Nominee

The November 2024 Inside Nutley Podcast features internationally known hematologist and oncologist Dr. Andrew Pecora, MD, Chairman & CEO of Outcomes Matter Innovations, LLC, and founder, former Chief Innovations Officer and Vice President of Cancer Services of the John Theurer Cancer Center at the Hackensack University Medical Center. Dr. Pecora is a 1975 graduate of Nutley High School and a 2005 inductee into the Nutley Hall of Fame.
Dr. Pecora joins host Thomas Greco to discuss his amazing career from Lincoln School to the Memorial Sloan Kettering Cancer Center and beyond; how Nutley shaped his life and vocation; his incredible optimism for finding a cure for cancer in the near future; and much, much more.

Inside Nutley November 2024 with Dr. Andrew Pecora

In honor of Cervical Health Awareness Month, the National Cervical Cancer Coalition presents the Cervical Cancer Survivor Series. Across eight episodes, we share stories from cervical cancer survivors across the country, touching on topics including diagnosis, treatment, and survivorship, as well as advice for others whose lives are impacted by this preventable disease. We also talked to providers in the field to answer questions about screening prevention and treatment.

In this episode we speak to Barbara Moscicki, a pediatrician and HPV expert. Dr. Moscicki explains cervical cancer screening in detail and helps us understand the follow-ups we may need if we have an abnormal result. She also talks about the importance of the HPV vaccine and the possibility that we could eliminate cervical cancer.

Learn more about cervical cancer prevention at the National Cervical Cancer Coalition website at www.nccc-online.org/

Cervical Cancer Survivor Series: Barbara Moscicki

In this fascinating episode of the Project Purple Podcast, CEO & Founder Dino Verrelli welcomes Dr. Cosimo Commisso, interim director and deputy director of the NCI-designated Cancer Center at Sanford Burnham Prebys Medical Discovery Institute. A leader in cancer metabolism research, Dr. Commisso shares groundbreaking insights into how pancreatic cancer cells survive and thrive—and what that means for future treatments.

Dr. Commisso breaks down the complex science behind tumor microenvironments, metabolic vulnerabilities, and the latest advances in targeting pancreatic cancer at a cellular level. He also discusses the challenges researchers face, the hope emerging from new studies, and why funding for this research is more critical than ever.

Whether you're a patient, caregiver, advocate, or science enthusiast, this episode delivers a powerful look at the cutting edge of pancreatic cancer research and the fight for better treatments.
Subscribe to the Project Purple Podcast for more inspiring stories.
If you’d like to donate to Project Purple’s mission of a world without pancreatic cancer, please visit https://www.projectpurple.org/.

To learn more about Project Purple, visit https://www.projectpurple.org/ or follow us on social media at these links: https://www.facebook.com/Run4ProjectPurple 
https://www.instagram.com/projectpurple/ 
https://twitter.com/Run4Purple 
https://www.youtube.com/channel/UCgA8nVhUY6_MLj5z3rnDQZQ


Episode 309: Unlocking the Science of Pancreatic Cancer with Dr. Cosimo Commisso

Did you know that according to research provided by the American Cancer Society, more than 2 million Americans will be diagnosed with cancer in 2025? Tune in for an inspiring discussion with Mohit Manrao, Senior Vice President of US Oncology at AstraZeneca, on the rising caner rates among younger adults. 
 
Moments with Marianne airs in the Southern California area on KMET 1490AM & 98.1 FM, an ABC Talk News Radio Affiliate!  https://www.kmet1490am.com

Mohit Manrao, Senior Vice President and Head of the US Oncology Business Unit at AstraZeneca, is responsible for leading commercial strategy and maximizing performance of their expansive oncology portfolio. Prior to assuming his current role in 2022, Mohit served as Vice President, Global Franchise Head Lung Cancer since 2020. Mohit joined AstraZeneca in 2012, holding various roles at the market, regional, and global-level across geographies, including Head of UK Oncology and Head of Daiichi Sankyo Alliance Europe. Mohit’s education includes Bachelor of Technology, Mechanical Engineering, Punjab Technical University and Masters of Business Administration, Indian School of Business. https://www.astrazeneca.com

For more show information visit:
www.MariannePestana.com

Rising Cancer Rates in Younger Adults with Mohit Manrao from AstraZeneca

In this episode, we examine how machine learning and artificial intelligence (AI) are becoming essential tools for improving image analysis of 3D samples. These technologies are reshaping research workflows by making analysis faster and more insightful.

We speak with Professor Jens Christian Schwamborn, Professor of Cellular and Developmental Biology at the University of Luxembourg, and Professor Christophe Deben, Professor of Tumour Biology and Organoids at the University of Antwerp. They share their perspectives on the current challenges in 3D sample analysis and how AI is helping to solve them - reducing processing time and revealing previously inaccessible information.

We'll look at the key reasons behind AI’s growing use in 3D image analysis, identify the limitations of existing imaging technologies, and explore how AI is evolving to handle increasingly complex data. We'll also discuss how the availability of large datasets is accelerating this shift and what breakthroughs AI could enable in the near future.

Machine Learning and AI in Enhancing Image Analysis of 3D Samples

This episode, 'Translating Promising Drug Candidates from Preclinical Screening to Clinical Trials,' will explore the challenges and successes of moving promising drug candidates from preclinical screening to clinical trials in oncology.

Join Dr. Steve Shnyder, Associate Professor at the Institute of Cancer Therapeutics, University of Bradford, as he explores:

- The unique challenges in oncology drug development.
- Preclinical model limitations and needed innovations.
- Translating preclinical insights into effective clinical trial design.
- The role of AI and machine learning in overcoming development hurdles.
- Real-world case studies of successful oncology drug approvals.



ranslating Promising Drug Candidates from Preclinical Screening to Clinical Trials

How is artificial intelligence being used in cancer care, and what do patients think about it?

In this 'Ask Me Anything' episode, Ellie Wolmark, Programme Manager for Integrated Cancer Medicine (ICM) at the CRUK Cambridge Centre, speaks with patient representatives Lorraine, Frankie, and Ann from across our Patient and Public Involvement groups, alongside ICM researchers Professor James Brenton, Dr Ines Machado, and Dr Gabriel Funingana from the University of Cambridge.

Together, they explore how artificial intelligence (AI) is being applied in cancer research, how it could support personalised treatment, and what the future might hold. The patients share thoughtful questions and concerns about the role of AI in healthcare, while the researchers explain how it's currently being used and what challenges remain.

This lively and insightful discussion highlights just how valuable patient involvement is in shaping research that truly meets the needs of those it aims to help.

Ask me anything about cancer

Ask me anything about... the use of artificial intelligence in healthcare

Why does eating more not fix the severe weight loss seen in some cancer patients, and what can be done about it?

In this 'Ask Me Anything' episode, Dr Hui-Ling Ou, Programme Manager for the Pancreatic Cancer and Cancer Immunology Programmes at the CRUK Cambridge Centre, speaks with researchers from the Cancer Cachexia Action Network (CANCAN): Dr Claire Connell (University of Cambridge and Cambridge University Hospitals NHS Foundation Trust), Dr David Lewis (CRUK Scotland Institute), and Dr Tobias Janowitz (Cold Spring Harbor Laboratory).

Together, they unpack what cancer-associated cachexia is, why it's so devastating for patients, and how scientists are working to understand and reverse this syndrome. The guests share how their research, spanning metabolism, imaging, immunology, and clinical studies, is bringing fresh insights and hope to a problem that affects quality of life for so many.

This thought-provoking discussion shines a light on the collaborative efforts driving progress against one of cancer's most challenging complications.

Ask me anything about... the science of cancer-associated cachexia

Conversations with integrative oncology practitioners and healing stories from people navigating cancer.

CheapShow is a comedy podcast all about getting the very best out of the worst! Be it Poundlands, Charity Shops, Car Boot Sales or Bargain Bins, hosts Paul Gannon & Eli Silverman poke around in the corners of the high streets and internet to find treasure in the trash.

One week it could be a studio based show, the next, a live comedy event. It could even be a location report or a scripted adventure! A few things it is, however, is rude, crude, silly and drizzled in pop culture, nostalgia and plenty of verbal violence!

It has guests, videos, songs, reviews, games and dares.  We apologise in advance!
www.thecheapshow.co.uk

The Sex+Health podcast from the American Sexual Health Association covers all aspects of sexual health. Featuring interviews with medical professionals and experts in the field of sexuality, Sex+Health aims to offer information and resources to with the goal of helping people take charge of their sexual health and understand its importance to overall well being.

Europe's best independent music station based in Luxembourg! English speaking.

In a single moment your life can change!  “Moments with Marianne” is a transformative hour that covers an endless array of topics with the ‘best of the best.’ Her guest are leaders in their fields, ranging from inspirational authors, top industry leaders, business and spiritual entrepreneurs.  Each guest is gifted, and a true visionary!  A recognized leader in her own work, and while teaching others to develop, refocus, and grow; Marianne will bring the best guest, and sometimes a special surprise.  Don’t miss this – you never know just which ‘moment’ will change your life forever.

Join us on The James Cancer-Free World Podcast as we talk to the top scientists and doctors at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James). They’ll discuss – in easy-to-understand language – all the cutting-edge cancer research going on at Ohio State and how this is improving patient care and ultimately saving lives.

About the OSUCCC – James:
The OSUCCC – James strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Since 1976, the OSUCCC – James has been a National Cancer Institute-designated Comprehensive Cancer Centers and one of only a few centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs. As the cancer program’s adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet ® designation, the highest honor an organization can receive for quality patient care and professional nursing practice.

Project Purple's vision is a world without pancreatic cancer. We have two initiatives: to help pancreatic cancer patients and fund research. With a variety of partners in the health and fitness world, our podcast will deliver an exciting look into our own background as well as the worlds of medical treatment, marathon running, crossfit, nutrition, stories of survival, inspiration, hope, and much more.

The Cancer Research UK Cambridge Centre unites over 1,000 world-leading biologists, chemists, physicists, engineers, mathematicians, computer scientists, clinicians, nurses and allied healthcare professionals from across Cambridge, UK to tackle cancer from every angle.

Our mission is to end death and disease caused by cancer through research, treatment and education. We are detecting cancer at its earliest stage and are developing personalised treatments for every patient through facilitating new collaborations and driving the translation of new scientific discoveries into clinical applications to improve patient care. By working together across a range of different disciplines, our members are breaking down the barriers between the laboratory and the clinic, enabling patients to benefit from the latest innovations in cancer science.

New tracks tagged #Cancer Research